71
Participants
Start Date
April 30, 2011
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Cardiox FDS
The Cardiox Shunt Detection system consists of a sensor placed in contact with the outer ear, similar to a finger probe used to detect oxygen levels in blood. Through an intravenous line, ICG (indocyanine green) at a dosage of 10 mg (2 mL of 5 mg/mL ICG solution) per test, is administered into the right or left antecubital fossa. The presence of ICG in the veins within the outer ear are detected, and the results are displayed on a monitor. All patients will also be evaluated with TCD and TEE for the presence of RTLS.
Columbia University Medical Center, New York
University of Alabama, Birmingham, Birmingham
Riverside Methodist Hospital, Columbus
Heart and Vascular Center of Arizona, Phoenix
UCLA Medical Center, Los Angeles
Swedish Hospital, Seattle
Tufts Medical Center, Boston
Lead Sponsor
Cardiox Corporation
INDUSTRY